Small Molecule Contract Services: Testing & Manufacturing
Small Molecule synthesis, from preclinical to commercial quantities
With Millipore® CTDMO Services we support small molecule API synthesis projects from milligram to commercial quantities. We are the partner to address the most difficult challenges, whether the target is difficult to handle, synthesize, or source. With a true consultative and partnered approach, our services reduce complexity and minimize program risk in a cost-effective manner.
Clients can speed up drug development by partnering with us on any of the following types of programs: HPAPIs, APIs, Next-Generation Conjugates, Linker-Payloads, PEGs, or Targeted Protein Degradation.
Our Track Record
#1
World's largest single-digit nanogram OEL CTDMO provider
30+
Years of experience in small molecule development and production
7
Small molecule modality targets
70,000
Square foot HPAPI expansion in Verona, WI
2
New large scale API production lines opening in Europe
Your Drug Journey
Our Offering
A Global Footprint
We are a single organization with a global network to deliver CDMO services across all stages of the molecule value chain.
Commercialization for large scale API production and portfolio lipids. Continued investment to expand our global network of API production facilities offers immediate development and manufacturing capacity..
Development, manufacturing and launch site for lipids, functionalized polyethylene glycols (PEGs), and APIs.
Our API and HPAPI manufacturing sites are SafeBridge certified. Continued investment and expansion in these facilities build upon our decades of high potency expertise and makes us one of the largest single-digit nanogram OEL CTDMO providers in the world.
Our ADC & Bioconjugation Center of Excellence offers ADC and Bioconjugation capabilities from pre-clinical development to commercial manufacturing.
Related Technical Resources
- Benefits of Monodisperse Activated PEGs in ADC Development
In this white paper, we explore monodisperse polyethylene glycols help overcome hydrophobicity challenges.
To continue reading please sign in or create an account.
Don't Have An Account?